APA

van Herwaarden N., Herfkens-Hol S., van der Maas A., van den Bemt B. J. F., van Vollenhoven R. F., Bijlsma J. W. J. & den Broeder A. A. (20140812). Dose reduction of tocilizumab in rheumatoid arthritis patients with low disease activity. : Clinical and experimental rheumatology.

Chicago

van Herwaarden N, Herfkens-Hol S, van der Maas A, van den Bemt B J F, van Vollenhoven R F, Bijlsma J W J and den Broeder A A. 20140812. Dose reduction of tocilizumab in rheumatoid arthritis patients with low disease activity. : Clinical and experimental rheumatology.

Harvard

van Herwaarden N., Herfkens-Hol S., van der Maas A., van den Bemt B. J. F., van Vollenhoven R. F., Bijlsma J. W. J. and den Broeder A. A. (20140812). Dose reduction of tocilizumab in rheumatoid arthritis patients with low disease activity. : Clinical and experimental rheumatology.

MLA

van Herwaarden N, Herfkens-Hol S, van der Maas A, van den Bemt B J F, van Vollenhoven R F, Bijlsma J W J and den Broeder A A. Dose reduction of tocilizumab in rheumatoid arthritis patients with low disease activity. : Clinical and experimental rheumatology. 20140812.